Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
In Cancer
100%
Leukemia
100%
Overall Survival
100%
Gene Expression Level
100%
HER2 mutation
100%
Metastatic Colorectal Cancer (mCRC)
100%
Progression-free Survival
83%
Cetuximab
83%
HER2 Expression
83%
Hazard Ratio
66%
Bevacizumab
66%
Gene Expression
50%
Next-generation Sequencing
33%
NanoString
33%
Human Epidermal Growth Factor Receptor 2 (HER2)
33%
HER2 Amplification
33%
Tumor Expression
16%
Treatment Selection
16%
Tumor Tissue
16%
Predictive Value
16%
Low Expression
16%
Prognostic Value
16%
Time-to-event Endpoint
16%
Gene Panel
16%
Tumor DNA
16%
Long Progression-free Survival
16%
Objective Response Rate
16%
Overall Survival Benefit
16%
First-line Chemotherapy
16%
FoundationOne CDx
16%
Plateau Effect
16%
Nursing and Health Professions
Malignant Neoplasm
100%
Leukemia
100%
Overall Survival
100%
Metastatic Colorectal Cancer
100%
Gene Expression Level
100%
Progression Free Survival
85%
Cetuximab
71%
Hazard Ratio
57%
Bevacizumab
57%
Neoplasm
42%
Next-Generation Sequencing
28%
Predictive Value
14%
Chemotherapy
14%
Immunology and Microbiology
Overall Survival
100%
Gene Expression Level
100%
Colorectal Carcinoma
100%
Progression Free Survival
85%
Cetuximab
71%
Bevacizumab
57%
Gene Expression
42%
Next Generation Sequencing
28%
Arm
14%